For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Taysha Gene Therapies Inc’s stock clocked out at $2.73, down -0.36% from its previous closing price of $2.74. In other words, the price has decreased by -$0.36 from its previous closing price. On the day, 1.27 million shares were traded. TSHA stock price reached its highest trading level at $2.79 during the session, while it also had its lowest trading level at $2.65.
Ratios:
To gain a deeper understanding of TSHA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.35 and its Current Ratio is at 5.35. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on July 11, 2025, initiated with a Buy rating and assigned the stock a target price of $8.
On June 27, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.Piper Sandler initiated its Overweight rating on April 09, 2024, with a $9 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 30 ’25 when Manning Paul B bought 750,000 shares for $2.75 per share. The transaction valued at 2,062,500 led to the insider holds 2,841,704 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSHA now has a Market Capitalization of 713976896 and an Enterprise Value of 531062496. For the stock, the TTM Price-to-Sale (P/S) ratio is 98.89 while its Price-to-Book (P/B) ratio in mrq is 10.17. Its current Enterprise Value per Revenue stands at 73.514 whereas that against EBITDA is -6.436.
Stock Price History:
The Beta on a monthly basis for TSHA is 0.96, which has changed by 0.29999995 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, TSHA has reached a high of $3.31, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is 4.82%, while the 200-Day Moving Average is calculated to be 33.78%.
Shares Statistics:
It appears that TSHA traded 3.93M shares on average per day over the past three months and 2860830 shares per day over the past ten days. A total of 261.53M shares are outstanding, with a floating share count of 213.39M. Insiders hold about 18.41% of the company’s shares, while institutions hold 66.29% stake in the company. Shares short for TSHA as of 1752537600 were 43962246 with a Short Ratio of 11.18, compared to 1749772800 on 33272908. Therefore, it implies a Short% of Shares Outstanding of 43962246 and a Short% of Float of 18.879999.
